Open Orphan plc changed its name to hVIVO plc on 26 October 2022, learn more
here
.
About Us
About hVIVO
Leadership Team
Our Companies
Key Stats
History
Services
Challenge Trials
RSV
Influenza
COVID-19
HRV
Malaria
Asthma & COPD
Laboratory Services
Assay Development
Field Trial Bio-logistics
Cell Based Assays
Molecular Services
Compound Efficacy & VRM
Biomarker Analysis
Phase II-III Clinical Trials
Vaccine Phase II-III Trials
Articles & Research
News & Media
Regulatory News
Media Coverage
Media Press Kit
Video Library
Events
Investors
New
Investors
Regulatory News & Email Alerts
Results Centre
Share Price Information
Events & Presentations
Environmental, Social & Governance
AIM Rule 26
Advisors
Documents
Corporate Governance
Volunteers
Careers
Contact Us
Contact Us
Articles & Research
from hVIVO
Article Types Filter
Article Types Filter
Blog
Article
Presentation
Scientific Paper
Factsheet
Case Study
Article Count
1 - 10 of 35 posts
Blog
20 Mar 2023
Advantages to Centralising Laboratory Services at hVIVO
Clinical field studies are a critical part of the drug development and approval process. They are conducted to evaluate the safety, immunogenicity, and efficacy of a new drug. These studies...
Read more
Blog
07 Mar 2023
EMA’s updated guideline to include broader coverage on Human Challenge Trials
View Link
Blog
20 Feb 2023
Advantages of Human Challenge Studies (Part 1)
Human challenge studies or controlled human infection model (CHIM) studies are Phase Ib or Phase IIa clinical trials, in which study participants, i.e. healthy volunteers, are deliberately exposed to infectious...
Read more
Article
07 Feb 2023
Accelerated regulatory pathways: Vaccines for tropical diseases
View Link
Article
24 Nov 2022
Human Clinical Trials: A Tool in the Fight Against Infectious Diseases
International Clinical Trials, Autumn 2022, pages 94-97. © Samedan Ltd
View Link
Presentation
03 Oct 2022
RSV Vaccines/Prophylactics: Key learning from the RSV challenge model and efficacy of vaccines
View Link
Presentation
03 Oct 2022
Initial characteristics of respiratory viruses in symptomatic subjects during the pandemic, a cohort study
View Link
Presentation
03 Oct 2022
Immunomodulators and treatment of disease in the influenza human challenge model
View Link
Blog
24 Aug 2022
Human Challenge Studies: Their Conduct and Safety Aspects
If there would be a survey of 100 clinical research professionals either from CRO or from Pharma/Biotech industry to explain what a human challenge study is, the most common answer...
Read more
Scientific Paper
17 Aug 2022
Treatment with the P2X3-Receptor Antagonist Gefapixant for Acute Cough in Induced Viral Upper Respiratory Tract Infection: A Phase 2a, Randomized, Placebo-Controlled Trial
View Link
Article Pagination
1
2
3
4
Articles Per Page
Articles Per Page
8
10
16
24
32
angle-down
meetup
chevron-down